APCETH GMBH & CO. KG
Patent Owner
Stats
- 4 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Jan 04, 2018 most recent publication
Details
- 4 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 90 Total Citation Count
- Feb 24, 2001 Earliest Filing
- 7 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0000,969 GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING ALPHA-1 ANTITRYPSIN (AAT)Jan 08, 16Jan 04, 18[A61K, C12N]
2017/0239,297 GENETICALLY MODIFIED MESENCHYMAL STEM CELLS EXPRESSING AN IMMUNE RESPONSE-STIMULATING CYTOKINE TO ATTRACT AND/OR ACTIVATE IMMUNE CELLSAug 18, 15Aug 24, 17[A61K, C07K]
2016/0008,401 PROTECTION OF THE VASCULAR ENDOTHELIUM FROM IMMUNOLOGICALLY MEDIATED CYTOTOXIC REACTIONS WITH HUMAN CD34-NEGATIVE PROGENITOR CELLSFeb 28, 14Jan 14, 16[A61K, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0238,541 CD34 STEM CELL-RELATED METHODS AND COMPOSITIONSAbandonedMay 08, 15Aug 27, 15[A61K, C07K]
2014/0322,786 POLYMER MODIFIED SUBSTRATES, THEIR PREPARATION AND USES THEREOFAbandonedNov 13, 12Oct 30, 14[B05D, C08F]
2012/0208,769 Chemokine-Mucin Fusions Linked to Glycosylphosphatidylinositol (GPI)-Anchors in Tissue Regeneration and as Tumour Immune AdjuvantsAbandonedNov 30, 06Aug 16, 12[A61K, C12N, A61P, C07K]
2011/0268,714 CD34 Stem Cell-Related Methods and CompositionsAbandonedJul 08, 11Nov 03, 11[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.